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Background. Evolutionary dynamics plays a central role in facilitating the mechanisms of species divergence among
pathogenic and saprophytic mycobacteria. The ability of mycobacteria to colonize hosts, to proliferate and to cause diseases
has evolved due to its predisposition to various evolutionary forces acting over a period of time. Mycobacterium indicus pranii
(MIP), a taxonomically unknown ‘generalist’ mycobacterium, acts as an immunotherapeutic against leprosy and is approved for
use as a vaccine against it. The large-scale field trials of this MIP based leprosy vaccine coupled with its demonstrated
immunomodulatory and adjuvant property has led to human clinical evaluations of MIP in interventions against HIV-AIDS,
psoriasis and bladder cancer. MIP, commercially available as ‘Immuvac’, is currently the focus of advanced phase III clinical
trials for its antituberculosis efficacy. Thus a comprehensive analysis of MIP vis-a`-vis evolutionary path, underpinning its
immanent immunomodulating properties is of the highest desiderata. Principal Findings. Genome wide comparisons
together with molecular phylogenetic analyses by fluorescent amplified fragment length polymorphism (FAFLP),
enterobacterial repetitive intergenic consensus (ERIC) based genotyping and candidate orthologues sequencing revealed
that MIP has been the predecessor of highly pathogenic Mycobacterium avium intracellulare complex (MAIC) that did not
resort to parasitic adaptation by reductional gene evolution and therefore, preferred a free living life-style. Further analysis
suggested a shared aquatic phase of MAIC bacilli with the early pathogenic forms of Mycobacterium, well before the latter
diverged as ‘specialists’. Conclusions/Significance. This evolutionary paradigm possibly affirms to marshal our
understanding about the acquisition and optimization of virulence in mycobacteria and determinants of boundaries therein.
Citation: Ahmed N, Saini V, Raghuvanshi S, Khurana JP, Tyagi AK, et al (2007) Molecular Analysis of a Leprosy Immunotherapeutic Bacillus Provides
Insights into Mycobacterium Evolution. PLoS ONE 2(10): e968. doi:10.1371/journal.pone.0000968
INTRODUCTION
Genus Mycobacterium represents some of man’s most potent
microbiological adversaries like M. tuberculosis (MTB), the tuber-
culosis (TB) causing bacterium that is responsible for the loss of
more than 50,000 human lives every week, globally. Also, leprosy
caused by M. leprae, is still a major public health problem [1]
whereas M. avium and other ‘opportunist’ mycobacteria are the
major cause of disease and death in immune compromised hosts,
including HIV patients. Moreover, the advent of XDR [2] and
MDR [3] strains of MTB coupled to prevalence of HIV co-
infection and the emergence of TB-IRIS (Immune Responsive
Inflammatory Syndrome) [4], has exacerbated the situation.
Despite better insights into the molecular basis of disease
pathogenesis, substantial gaps persist in our understanding of the
evolution of the soil-derived mycobacterial progenitors into
‘seasoned’ pathogens, and their effective prophylaxis.
Mycobacterium indicus pranii (MIP), formerly Mycobacterium w [5], is
an atypical saprophytic bacterium that was listed in Runyon
Group IV, along with M. fortuitum, M. smegmatis, M. chelonae and M.
vaccae, based on its growth and metabolic properties [6]. MIP, in
an extended phase III clinical trial in India, was used as an adjunct
to the standard multidrug therapy with multibacillary leprosy
patients and showed a significantly enhanced bacillary clearance,
thus, shortening the full recovery time [6,7]. MIP, commercially
available as ‘‘Immuvac’’ vaccine, also exhibited immunoprophy-
lactic benefits in household contacts of leprosy patients in the
largest ever clinical trial in India [8]. It not only shares antigens
with M. leprae and M. tuberculosis but also provides protection to
both BCG responder and non-responder genetic strains of mice
against M. tuberculosis H37Rv infection [9]. Based on a strong
indication of its immuno-therapeutic role in category II tubercu-
losis patients [10], large-scale phase III trials are currently in
progress to evaluate its anti-tuberculosis efficacy. MIP is also under
clinical trials as an immuno-modulator and adjuvant, based on
encouraging findings about its role in HIV [11], bladder cancer
[12] and psoriasis [13].
To optimally harness the therapeutic potential of MIP, it is
imperative to understand how MIP shaped its exceptional
immunomodulating properties akin to a philanthropic vaccine strain
without embracing the dreadful pathogenic attributes of MTB.
Conventionally, evolutionary and comparative genomic studies have
been Rosetta stone to gain insights into mycobacterial divergence
and acquisition of virulence therein. The epistemological studies
involving extensive genomic characterization of MIP using several
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molecular tools and markers along with the comparative genomic
studies with its whole genome data reveal that MIP has been the
predecessor of MAIC bacilli and shared a common aquatic phase
with early pathogenic forms of mycobacteria thus, presenting
a holistic picture of Mycobacterium evolution.
RESULTS
MIP belongs to MAIC
MIP genomic DNA was subjected to different diagnostic PCRs
targeted at signature sequences such as internal transcribed spacer
(ITS) region between rrn16 and rrn23 genes and 65 kDa heat shock
protein (hsp65) gene (Figure 1). The amplicons corresponding to
these loci were sequenced and aligned to evaluate sequence
similarity of MIP with other mycobacterial bacilli. The ITS region
matched perfectly well with the corresponding region of M.
intracellulare (Figure 1C) pointing to the possible genetic affinity of
MIP to MAIC complex. In hsp65, all the four nucleotide
substitutions, reported as MIP signatures, were identified at the
right locations, thereby confirming the identity of MIP used in this
study [14]. The IS900 specific PCR, considered as a signature for
MAPC (M. avium subsp. paratuberculosis complex) bacilli, however,
did not yield PCR product specific to MAPC (Figure 1), thereby
excluding an evolutionary link between MIP and MAPC. The three
principle genetic groups (PGG) based on the single nucleotide
polymorphisms of katG 463CTG (Leu) and gyrA 95ACC (Thr) (15)
showed that MIP and MAIC bacilli belong to group 1 (primitive)
that includes pathogenic branch members like M. marinum, M.
ulcerans and MTB W-Beijing strain.
Phylogenetic placement
FAFLP [16] and ERIC [17] are the whole genome based cardinal
genotyping approaches that complement the piecemeal studies
with candidate genes that may be influenced by horizontal gene
transfer events in closely related species. FAFLP analysis
(Figure 2A) as well as ERIC based molecular typing revealed
considerable genetic similarity of MIP with MAIC (Figure 3). MIP,
along with the members of MAIC, formed a separate group. This
method did not reveal any significant genetic similarity between
the bacilli belonging to M. tuberculosis complex (MTBC) and MIP.
All the pathogenic species, including M. leprae, formed a separate
cluster. MIP was found to be genetically linked to M. intracellulare
and M. abcessus. All the candidate gene sequences upon alignment
with known databank sequences of MTBC, MAPC, MAIC and
other non-tuberculous mycobacteria (NTMs), revealed substantial
Figure 1. Confirmation of the genetic signatures of MIP (A) PCR with ITS region sequences showing a ,350 bp amplicon, M-100 bp marker (B)
MIP strain confirmation PCR with hsp65 gene region, M-100 bp marker. This 441 bp amplicon was having all the 4 unique substitutions known for
MIP (C) Sequence alignment of ITS sequence ofMIP withMAIC organism (D) IS900 PCR to rule out MAPC lineage-M: marker, Lane 1:M. paratuberculosis
control PCR, lanes 2 and 3: MIP.
doi:10.1371/journal.pone.0000968.g001
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Figure 2. Phylogenetic trees based on FAFLP and multigene sequence analyses. A. Polymorphic fragments were subjected to allele calling in
Genotyper (Applied Biosystems, USA) and allele scoring was recorded in a binary format. This binary data were used to construct a phylogenetic
tree (please see methods). B. Phylogenetic tree constructed based on consensus multigene alignment which involved concatenation of individual
gene sequences corresponding to rpoB, recA, sodA, rrn16 and hsp65. Bootstrap values conveying significance of the internal branch topology are
clearly marked near each branch. Values above 50 were deemed to be significant to convey correct topology of the internal branches.
doi:10.1371/journal.pone.0000968.g002
Mycobacterial evolution
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sequence similarities between MIP and MAC as well as MAIC
bacilli. Construction of a phylogenetic tree based on concatenated
multigene ‘‘super locus’’ comprising of sequences derived from
rrn16, sodA, hsp65, rpoB and recA eventually placed MIP into MAIC
cluster [18]. MIP DNA sequences corresponding to candidate
orthologues have been deposited to Genbank (DQ437715-
437722).
The phylogeny with gyrB [19] and 32 kDa protein genes [20],
which are crucial to infer evolutionary relationship in closely
related species also confirmed the above findings (Figure S1). The
32 kDa protein coding gene, despite having an identical sequence
in strains belonging to M. tuberculosis complex (M. tuberculosis, M.
bovis, M. bovis BCG and M. microti), considerably differs at the
nucleotide level in case of M. avium and M. intracellulare [20].
Likewise, gyrB gene is a house-keeping gene, found in almost all
bacteria and does not appear to be frequently horizontally
transmitted [21]. The alignment of gyrB of MAIC bacilli and
MIP showed just one substitution in MIP sequence with respect to
M. intracellulare as compared to 119 of MAP (Figure S2). This
almost 100% conservation of gyrB between MIP and M.
intracellulare is surprising since gyrB evolves rapidly due to its faster
evolution rate. In case of 32 kDa protein coding gene, similar
analysis of MIP with that of M. avium complex revealed 98%
similarity with M. intracellulare as compared to 93% of MAP (Figure
S3), thus firmly establishing phylogenetic proximity of MIP to
Mycobacterium intracellulare.
Evolution of mycobacterial ‘generalists’ versus
‘specialists’
The comparative genome analyses have been employed to dissect
the intricate mechanisms of ancient and contemporary dissemi-
nation and evolution of mycobacteria [22,23]. Considering their
broadly clonal population structure, it has been hypothesized that
a single strain may not have a sufficiently divergent genetic
material to qualify for a species status and, therefore, speciation in
Mycobacterium most likely has arisen due to specific deletion events
[22]. Lately, several genomic regions of deletions (RDs),
considered as an important evolutionary paradigm in mycobac-
teria, have been shown to be associated with the attenuation of
virulence [23,24]. The analyses revealed that MIP has shown
a congruent pattern of RD’s with respect to the members of MAIC
and a similar pattern with that of early pathogenic members of
MTBC like M. marinum and M. ulcerans. The RD1 locus, encoding
ESAT6 and CFP10 proteins putatively associated with virulence,
was absent in MIP and MAIC bacilli, but present in M. marinum.
While RD4 is absent in M. ulcerans, it is only partially deleted in M.
marinum. In M. ulcerans, ESAT6 and CFP10, known to enhance
DNA transfer, are deleted [25]. Acquisition of plasmids in the
early group of bacilli, with some deficient in RD1, appears to be
a faster mode to gain novel functions for diversification as
exemplified by similar synonymous substitution frequencies for
plasmid and chromosomal encoded genes in M. ulcerans [26].
Likewise, RD3 and RD11 are absent in MIP and MAIC as well as
in M. marinum, M. ulcerans and M. canetti, but RD2 is present in M.
canetti (Table 1). Similarly, MIP and MAIC bacilli can be typified by
the absence of RD6 region. It is noteworthy that RD6 constitutes
IS1532 transposase integrations while RD3 and RD11 represents
phiRv phage based integrations into the genomes that may be
helpful to generate antigenic diversities. The presence of these
regions in the subsequent MTBC members, however, suggests that
these were deleted only in some lineages of tubercle bacilli.
Alternatively, these regions might have been regained via phiRv
phage based transductions in recently evolved MTBC members.
Furthermore, the evaluation of MIP, based on whole genome
data at 10X coverage (Saini et al, unpublished), revealed that its
genome content is ,20% in excess to that of M. avium. The
phylogenetic data in light of genome size evaluation placed MIP
way ahead of MAIC bacilli on an evolutionary time scale (Figure 4).
Also, M. marinum, in pathogenic branch, and M. smegmatis together
with MIP, within the ‘generalist’ branch, appear as the immediate
descendants of the ancient mycobacterial progenitor (Figure 4).
DISCUSSION
The saprophytic mycobacteria are believed to play a protective
role in chronic infections like asthma and TB [27]. However,
clinical trials with saprophytic M. vaccae didn’t benefit TB patients
and led to local adverse reactions in recipients [28]. Contrarily,
MIP, besides giving protection against TB and AIDS infections,
Figure 3. ERIC analysis of MIP, other tubercle bacilli and NTMs. A.
ERIC based fingerprinting. B. Phylogenetic analysis. Polymorphic ERIC
fragments were subjected to allele calling in Quantity 1 software
(Biorad, USA) and scoring was recorded in a binary format. These binary
data were used to construct a phylogenetic tree developed using
bootstrapping methods in MEGA software. Bootstrap values for the
internal branch topology are clearly marked near each branch. Values
above 50 were assumed as significant to convey acceptable topology of
the internal branches.
doi:10.1371/journal.pone.0000968.g003
Mycobacterial evolution
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elicits immune responses even in the heat inactivated form [29,30].
Considering variable BCG efficacy and increasing HIV/TB
pandemic, alternate strategies involving MIP are pertinent to
confront this deadly duo that has caused nearly 150 million deaths
since World War I-more total deaths than in all wars in the last
2000 years [31].
The phylogenetic link of saprophytic MIP to the non-tubercle
MAIC bacilli came as a surprise especially as all the members of
this ilk are slow growers that are only second to MTBC bacilli in
terms of their ability to infect immune compromised humans and
are classically termed as ‘pathogens’. Besides, they are believed to
be responsible for Crohn’s disease in humans and John’s disease in
ruminants, especially dairy cattle, causing extensive economic loses
to farmers. MAIC bacilli, though formally divided into M. avium
subsp avium (MAA), M. avium subsp paratuberculosis (MAP) and M.
intracellulare, remain a challenge to mycobacterial taxonomy due to
high heterogeneity within their constituent species. Although the
evolution of highly niche adapted parasitic forms by genomic
downsizing is an accepted norm in MTB [24,32], the details
remain obscure for MAIC bacilli. The adaptation of an organism
to parasitic lifestyle in a particular host renders various metabolic
gene functions redundant due to non-functionalization or
pseudogenization of some genes or deletion of the large genomic
chunks and the host machinery is utilized to cater these metabolic
needs. M. leprae, Shigella flexneri and Salmonella typhi have undergone
similar miniaturization by extensive genome reduction [33]. The
genome content could, as per this analogy, be inversely pro-
portional to the fitness of the organism in animal hosts. When we
look at the genetic similarity of MAIC or MAPC bacilli to MIP in
the light of its genome size, it is evident that the former are highly
pathogenic and evolved organisms that have shed genes
detrimental to pathogenic lifestyle in particular niches.
Since mycobacteria have a restricted synonymous polymor-
phism rate [15], this implies that deletion or acquisition of the
genes might be a more important mechanism than point
mutations for generating niche specific evolutionary novelties.
The evidence has emerged for lateral gene acquisitions unique to
MAC, absent in MTB and MAP, facilitating its intracellularization
in protozoic hosts [34]. Similarly, a significant chunk (,4%) of
MAP genome is reportedly shaped up by lateral gene acquisitions
[35]. Interestingly, MIP and MAA harbor about 60% and 75%
(E,1025) of the genes reported to be laterally acquired in MAP,
most of them proteobacterial in origin (Saini et al, unpublished).
These findings are consistent with the ability of MAIC bacilli to
survive in an extensive range of habitats including soil and water
despite their extreme genetic homogeneity and a low rate of
recombination. The presence of laterally acquired gene homolog
of rsbR, a possible sigma B regulator, in MIP and MAIC might be
seen as one of the plausible mechanisms to overcome stress as this
gene has been found to be a positive regulator of sigB under stress
conditions in B. subtilis [36]. On the other hand although MTBC
bacilli appear to be relatively non-amenable to lateral gene
acquisition [37], yet only M. marinum and M. ulcerans, the early
pathogenic branch members (‘‘specialists’’), were found to possess
significant proportions of these genes reported to be laterally
acquired in MAP (13% and 7.5%, respectively, data not shown).
The proteobacterial origins of such major chunk of genome in
MIP and MAIC bacilli and a similar RD profile of these bacilli with
respect to early pathogenic lineage of MTBC envisage plausible
similarities in early life style of the ‘generalist’ and ‘specialist’
groups. Since lateral gene transfers are influenced by physical
proximity, it is tempting to speculate that earliest pathogenic and
non-pathogenic members of Mycobacterium might have shared
a common aquatic phase before diversification [38] (Figure 4).
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Our findings, thus, in the light of above discussion provide
a novel perspective of mycobacterial evolution and we
hypothesize that the progenitors of MAIC and MTBC could
have been soil dwelling microbes like MIP that preferred water
bodies, probably due to nutritional needs and shared a common
aquatic phase in their early life history. These bacilli sub-
sequently augmented their fitness for niche specific adaptations
by tuning their genomic repertoires with a constant genetic flux
aided by extensive and selective lateral gene acquisitions counter
balanced by a directional genome decay concomitant with their
wide host range. Also, in the backdrop of MIP’s congruent RD
profile with opportunistic MAIC, it appears that immunomodula-
tion in MIP, unlike M. bovis BCG, may not be due to selective
deletion events but rather it is the selective acquisition of genes
that shaped up its antigenic repertoire. It, therefore, becomes
perceptible that MIP existed in nature much before the
divergence of MAIC and MAPC and, therefore, could well be
the ancestor of the MAIC bacilli that did not parasitize human
or animal niches. It has not escaped our notice that the genetic
similarity between MIP and MAP immediately suggests a plausi-
ble advantage for therapeutic intervention against Crohn’s and
Johne’s diseases.
MATERIALS AND METHODS
Bacterial cultures and DNA samples
MIP stock culture was a kind gift from Rajani Rani, National
Institute of Immunology, New Delhi, India. The bacteria were
streaked onto Middlebrook (MB) 7H11 agar plate supplemented
with 1xOADC. Culture was also streaked onto LB agar to check for
any contaminating bacteria. Once the purity of the culture was
confirmed [14], MIP genomic DNA was isolated from culture grown
in Middlebrook (MB) 7H9 liquid medium supplemented with 0.5%
glycerol, 0.2% Tween-80, 1xADC with constant shaking (200 rpm)
at 37uC. The genomic DNA of MTB was obtained from the RIVM,
Bilthoven, Netherlands and the DNA of several other non-
tuberculous mycobacteria (NTMs) such as M. avium, M. intracellulare,
M. smegmatis, M. xenopi, M. abscessus, M. fortuitum/peregrinum, M.
scrofulaceum, M. fortuitum, M. gordonae, M. paratuberculosis, M. marinum
and M. kansasii were a gift from Leonardo A. Sechi, Dept. of
Biomedical Sciences, University of Sassari, Italy.
DNA fingerprinting and genotyping
DNA fingerprinting by fluorescent amplified fragment analysis was
performed as described previously [16,39]. Briefly, the profiling of
Figure 4. Landscape of genome evolution across the ‘generalist’ and ‘specialist’ mycobacterial lineages. Various RDs refer to genomic deletion
points as discussed elsewhere [24]. Divergence of M. tuberculosis W-Beijing was deduced based on the RD105 [41]. The inferred time points of some
important lineage divergences mentioned as years-before-present (years BP) on the basis of the conventions established earlier [15,24,42]. For further
details please refer to manuscript text.
doi:10.1371/journal.pone.0000968.g004
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whole genome micro-restriction fingerprints with EcoRI/MseI
enzymes using fluorescence tagged primer pairs EcoRI+A/MseI+0
and EcoRI+G or A / MseI+0 was performed for all the strains. The
PCR amplified fragments for each of the strains were then subjected
to electrophoretic separation on a 5% acrylamide gel and scoring of
the fluorescent markers was done using an automated DNA analysis
workstation (ABI Prism 3100 DNA sequencer).
ERIC based genotyping was carried out by PCR using primers
ERIC1R (5-ATGTAAGCTCCTGGGGATTCAC) and ERIC2
(5-AAGTAAGTGACTGGGGTGAGCG). Amplification reac-
tions were performed in a total volume of 20 ml containing
50 ng of DNA, 1X PCR buffer (Applied Biosystems), 2 mM
MgCl2 (Applied Biosystems), 200 mM deoxynucleoside triphos-
phate, 20 picomoles of each primer and 2 U of Taq DNA
polymerase (Applied Biosystems, USA). The reaction mixtures
were incubated in GeneAmp PCR system 9700 for 2 min at 94uC,
followed by 35 cycles of 94uC for 45 s, 52uC for 1 min, and 70uC
for 10 min and a final extension at 70uC for 20 min as described
previously [17].
Comprehensive phylogeny and comparative
genomics
A comprehensive genomic characterization of MIP was carried out
based on several molecular signatures: i) FAFLP based high
resolution fingerprinting [16], ii) ERIC typing [17], iii) sequencing
of candidate orthologues corresponding to rrn16, hsp65, sodA, rpoB,
gyrB, recA, ITS and the 32 kDa protein coding gene [18,19,20] iv)
presence/absence of RDs [24,32], and, v) katG and gyrA
polymorphisms [15]. With respect to these features, MIP was
compared against 9 genome sequences of mycobacteria including
M. marinum, M. ulcerans, M. tuberculosis H37Rv, M. tuberculosis
CDC1551, M. bovis, M. bovis BCG, M. avium subsp paratuberculosis,
M. smegmatis and M. avium subsp avium. The genomes were
downloaded from NCBI (ftp://ftp.ncbi.nih.gov/genomes/Bacte-
ria/). Phylogenetic trees based on the candidate gene polymorph-
isms in either individual genes or their concatenated ‘super loci’
were obtained by using the neighbour joining method with
Kimura-2 parameter (K2P) and a distance correction model with
1000 bootstrap replicates [in MEGA3.1; 40]. In case of FAFLP
data, the trees were constructed using the binary data by minimum
evolution method with topology validated through an interior
branch test, a t-test, which is computed using the bootstrap
procedure. ERIC based phylogenetic trees were also obtained
based on binary data, but by using the neighbor joining method
with nucleotide p distance model with 100 bootstrap replicates [in
MEGA3.1; 40]. Internal branch topology was validated via the
interior branch test.
Whole-genome sequencing
The shotgun data for MIP genome were generated from paired
end sequences from whole genome shot gun libraries with an
average insert size of 2–3 kb and 4–5 kb using BDT (big dye
terminator) technology on ABI3700 DNA sequencers. The data
were subsequently assembled and analyzed using Phred/Phrap/
Consed package available from University of Washington, U.S.A.
SUPPORTING INFORMATION
Figure S1 Phylogenetic trees based on comparison of the DNA
sequences corresponding to gyrB gene (A) and 32kDa protein gene
(B) of MIP and other mycobacteria. Sequence alignment was
performed in Clustal W software and phylogenetic trees were
developed in MEGA3.1 using bootstrapping method.
Found at: doi:10.1371/journal.pone.0000968.s001 (0.11 MB PPT)
Figure S2 Alignment of gyrB of MIP with other members of
MAIC complex (M. avium and M. intracellulare)
Found at: doi:10.1371/journal.pone.0000968.s002 (0.15 MB PPT)
Figure S3 Alignment of 32kDa protein gene of MIP with other
members of MAIC complex (M. avium and M. intracellulare).
The identities are depicted by dots only.
Found at: doi:10.1371/journal.pone.0000968.s003 (0.12 MB PPT)
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